Mass spectrometry-based serum peptide profiling in hepatocellular carcinoma with bone metastasis.
about
Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner.Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia.Influence of honeybee sting on peptidome profile in human serum.Application Value of Mass Spectrometry in the Differentiation of Benign and Malignant Liver TumorsProteoglycans-Biomarkers and Targets in Cancer Therapy.
P2860
Mass spectrometry-based serum peptide profiling in hepatocellular carcinoma with bone metastasis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mass spectrometry-based serum ...... arcinoma with bone metastasis.
@ast
Mass spectrometry-based serum ...... arcinoma with bone metastasis.
@en
type
label
Mass spectrometry-based serum ...... arcinoma with bone metastasis.
@ast
Mass spectrometry-based serum ...... arcinoma with bone metastasis.
@en
prefLabel
Mass spectrometry-based serum ...... arcinoma with bone metastasis.
@ast
Mass spectrometry-based serum ...... arcinoma with bone metastasis.
@en
P2093
P2860
P356
P1476
Mass spectrometry-based serum ...... arcinoma with bone metastasis.
@en
P2093
Zhao-Chong Zeng
Zuo-Lin Xiang
P2860
P304
P356
10.3748/WJG.V20.I11.3025
P407
P577
2014-03-01T00:00:00Z